Regeneron Gene Therapy Wins FDA Fast Track, White House Drug Deal Looms
June 25, 2026·about 2 hours ago·via Stocktwits

Regeneron's breakthrough gene therapy for genetic hearing loss just got the FDA's accelerated approval stamp - a win for innovation and patients desperate for real solutions. The White House is announcing a drug pricing deal today, signaling the administration's willingness to work with pharma on affordability without crushing the incentives that drive medical breakthroughs. Read more about this...